✉news WorldUS Politics first seen 2 d ago, last 1 d ago, peak #30
LB Pharmaceuticals presents LB-102 data at ECNP congress
Original: LB Pharmaceuticals presents data on LB-102 at ECNP congress
LB Pharmaceuticals presented clinical data on its investigational drug LB-102 at the ECNP congress, a major European meeting on neuropsychopharmacology. The company shared findings on the compound, which is being developed as a potential treatment for psychiatric conditions. The presentation gives investors and clinicians an early look at the drug's profile as it advances through development.
Why now: New clinical data on an experimental psychiatric drug was unveiled at a major scientific congress, drawing attention from investors and the medical community.
Rank over time, top of the chart is #1. 6 snapshots from 2 d ago to 1 d ago.
Evidence
- LB Pharmaceuticals presents data on LB-102 at ECNP congress · Investing.com
API: https://socialmediatrends-api.osmike.com/v1/trends/1739298